Home > Insider Trading > Filing (0001209191-20-046449)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1305253	Eiger Biopharmaceuticals Inc.	EIGR	Biological Products, (No Disgnostic Substances) (2836)	361004130

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1670382	S Jeffrey Glenn	350 Cambridge Ave, Suite 350 Palo Alto CA 94306		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-11	5,000	$11.49	71,355	No	4	P	Direct
Common Stock	Acquisiton	2020-08-12	500	$11.28	500	No	4	P	Indirect	By spouse
Common Stock	Acquisiton	2020-08-12	4,500	$11.44	5,000	No	4	P	Indirect	By spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By spouse
No	4	P	Indirect	By spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	460	Indirect	By son
Common Stock	151,064	Indirect	By Eiger Group International, Inc.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.445 to $11.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.